Close Menu
Skip to main content
GenomeWeb
360Dx
Precision Oncology News
Precision Oncology News
*
*
Show password
Forgot your password?
Subscribe
Contains all of these words:
Business & Policy
Business News
Regulatory News
Reimbursement
Biomarkers
BRCA
EGFR
HER2
KRAS
BRAF
ROS1
ALK
PD-L1
Cancer Specialties
Breast Cancer
Lung Cancer
Colorectal Cancer
Prostate Cancer
Ovarian Cancer
Brain Cancer
Melanoma
Pediatric Cancer
Oncology Trends
Next-Generation Sequencing
Minimal Residual Disease
Microsatellite Instability Testing
Immunotherapy
Liquid Biopsy
Resources
Webinars
White Papers
Conferences & Events
Menu
Home
›
About Us
›
Our Staff
›
Victoria Macomber
Victoria Macomber
East Coast Media Sales Director
Phone Number
508-928-1255
Email
[email protected]
Breaking
News
MapKure, BeiGene, SpringWorks to Start Phase I Trial of BRAF Inhibitor in Solid Tumors
Puma's Neratinib sNDA Approved by FDA for HER2-Positive Metastatic Breast Cancer
iOnctura Doses First Patient in Phase I Study of Novel PI3K Inhibitor for Solid Tumors
Oncologie, Moffitt to Collaborate on Developing Targeted Treatment for Gastric and GI Cancers
GSK's sNDA for Ovarian Cancer Drug Zejula Accepted by FDA
Takeda's Alunbrig sNDA for ALK-Positive Non-Small Cell Lung Cancer Accepted by FDA
